NEW YORK (GenomeWeb News) — Blue Stream Laboratories has purchased a suite of Agilent Technologies’ proteomics products for its drug-development work, Agilent said today.
Boston-based Blue Stream has stocked its protein-characterization lab with Agilent's HPLC-chip and its 6210 time-of-flight mass spectrometer with MALDI and electrospray capabilities.
The deal also includes software and services that support the technology, Agilent said.
Blue Stream said its services includes analytical and in vitro biological method development, validation and testing, formulation support, and microbiological testing.
Financial terms of the agreement were not released.